(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348910 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBL1XR1 mRNA CTD PMID:22079256 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of TBL1XR1 mRNA CTD PMID:20068009 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1348910 6480464 Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to TBL1XR1 gene] CTD PMID:19574409 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TBL1XR1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TBL1XR1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558421 6480464 Tetrachlorodibenzodioxin affects the expression of TBL1XR1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TBL1XR1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558421 6480464 Tetrachlorodibenzodioxin results in increased expression of TBL1XR1 mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1348910 6480464 Tetrachlorodibenzodioxin results in decreased expression of TBL1XR1 mRNA CTD PMID:19574409 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of TBL1XR1 mRNA CTD PMID:21346803 3-methylcholanthrene multiple interactions ISO RGD:1348910 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to TBL1XR1 promoter] CTD PMID:20348232 4-hydroxynon-2-enal increases expression ISO RGD:1558421 6480464 4-hydroxy-2-nonenal results in increased expression of TBL1XR1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:1558421 6480464 Fenretinide results in decreased expression of TBL1XR1 mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of TBL1XR1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of TBL1XR1 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1348910 6480464 Aflatoxin B1 results in decreased methylation of TBL1XR1 intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:1348910 6480464 aflatoxin B2 results in decreased methylation of TBL1XR1 intron CTD PMID:30157460 aristolochic acid A decreases expression ISO RGD:1348910 6480464 aristolochic acid I results in decreased expression of TBL1XR1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1558421 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of TBL1XR1 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1348910 6480464 Arsenic affects the methylation of TBL1XR1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1348910 6480464 Arsenic affects the methylation of TBL1XR1 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:1348910 6480464 arsenite inhibits the reaction [G3BP1 protein binds to TBL1XR1 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO RGD:1558421 6480464 Benzo(a)pyrene results in decreased expression of TBL1XR1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1348910 6480464 Benzo(a)pyrene results in decreased methylation of TBL1XR1 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1348910 6480464 Benzo(a)pyrene affects the methylation of TBL1XR1 intron, Benzo(a)pyrene affects the methylation of TBL1XR1 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1348910 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[e]pyrene decreases methylation ISO RGD:1348910 6480464 benzo(e)pyrene results in decreased methylation of TBL1XR1 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TBL1XR1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1348910 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of TBL1XR1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1348910 6480464 bisphenol A results in increased expression of TBL1XR1 mRNA CTD PMID:33670352 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TBL1XR1 mRNA CTD PMID:33296240 , PMID:34947998 bisphenol A affects methylation ISO RGD:1558421 6480464 bisphenol A affects the methylation of TBL1XR1 promoter CTD PMID:27334623 butanal decreases expression ISO RGD:1348910 6480464 butyraldehyde results in decreased expression of TBL1XR1 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1348910 6480464 Cadmium Chloride results in increased expression of TBL1XR1 mRNA CTD PMID:26472689 carbon nanotube decreases expression ISO RGD:1558421 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1558421 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of TBL1XR1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of TBL1XR1 mRNA CTD PMID:18668222 cisplatin decreases expression ISO RGD:1348910 6480464 Cisplatin results in decreased expression of TBL1XR1 mRNA CTD PMID:19561079 , PMID:27392435 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL1XR1 mRNA CTD PMID:17602206 copper atom multiple interactions ISO RGD:1348910 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TBL1XR1 mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:1558421 6480464 Copper results in increased expression of TBL1XR1 mRNA CTD PMID:16629173 copper(0) multiple interactions ISO RGD:1348910 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TBL1XR1 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:1558421 6480464 Copper results in increased expression of TBL1XR1 mRNA CTD PMID:16629173 copper(II) sulfate decreases expression ISO RGD:1348910 6480464 Copper Sulfate results in decreased expression of TBL1XR1 mRNA CTD PMID:19549813 dexamethasone increases expression ISO RGD:1558421 6480464 Dexamethasone results in increased expression of TBL1XR1 mRNA CTD PMID:22733784 dicrotophos decreases expression ISO RGD:1348910 6480464 dicrotophos results in decreased expression of TBL1XR1 mRNA CTD PMID:28302478 disodium selenite decreases expression ISO RGD:1348910 6480464 Sodium Selenite results in decreased expression of TBL1XR1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1348910 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1558421 6480464 Doxorubicin results in increased expression of TBL1XR1 mRNA CTD PMID:25896364 doxorubicin decreases expression ISO RGD:1348910 6480464 Doxorubicin results in decreased expression of TBL1XR1 mRNA CTD PMID:29803840 ethanol affects expression ISO RGD:1558421 6480464 Ethanol affects the expression of TBL1XR1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1348910 6480464 Ethyl Methanesulfonate results in decreased expression of TBL1XR1 mRNA CTD PMID:23649840 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of TBL1XR1 mRNA CTD PMID:24793618 folic acid decreases expression ISO RGD:1558421 6480464 Folic Acid results in decreased expression of TBL1XR1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1348910 6480464 Formaldehyde results in decreased expression of TBL1XR1 mRNA CTD PMID:23649840 fulvestrant increases methylation ISO RGD:1348910 6480464 Fulvestrant results in increased methylation of TBL1XR1 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:1348910 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of TBL1XR1 gene CTD PMID:31601247 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of TBL1XR1 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of TBL1XR1 mRNA CTD PMID:24136188 glyphosate decreases expression ISO RGD:1348910 6480464 glyphosate results in decreased expression of TBL1XR1 mRNA CTD PMID:31295307 gold atom decreases expression ISO RGD:1348910 6480464 Gold results in decreased expression of TBL1XR1 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1348910 6480464 Gold results in decreased expression of TBL1XR1 mRNA CTD PMID:25523186 hydrogen peroxide affects expression ISO RGD:1348910 6480464 Hydrogen Peroxide affects the expression of TBL1XR1 mRNA CTD PMID:20044591 , PMID:23410634 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TBL1XR1 mRNA CTD PMID:22129741 isoprenaline increases expression ISO RGD:1558421 6480464 Isoproterenol results in increased expression of TBL1XR1 mRNA CTD PMID:20003209 isotretinoin increases expression ISO RGD:1348910 6480464 Isotretinoin results in increased expression of TBL1XR1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1348910 6480464 Ivermectin results in decreased expression of TBL1XR1 protein CTD PMID:32959892 lead diacetate decreases expression ISO RGD:1558421 6480464 lead acetate results in decreased expression of TBL1XR1 mRNA CTD PMID:25270620 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of TBL1XR1 mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:1348910 6480464 leflunomide results in increased expression of TBL1XR1 mRNA CTD PMID:28988120 melphalan decreases expression ISO RGD:1348910 6480464 Melphalan results in decreased expression of TBL1XR1 mRNA CTD PMID:22363485 menadione affects expression ISO RGD:1348910 6480464 Vitamin K 3 affects the expression of TBL1XR1 mRNA CTD PMID:23410634 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of TBL1XR1 mRNA CTD PMID:30467583 methapyrilene decreases methylation ISO RGD:1348910 6480464 Methapyrilene results in decreased methylation of TBL1XR1 intron CTD PMID:30157460 methotrexate decreases expression ISO RGD:1348910 6480464 Methotrexate results in decreased expression of TBL1XR1 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:1348910 6480464 Methyl Methanesulfonate results in decreased expression of TBL1XR1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1348910 6480464 methylmercuric chloride results in decreased expression of TBL1XR1 mRNA CTD PMID:28001369 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL1XR1 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TBL1XR1 mRNA CTD PMID:17602206 , PMID:22129741 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TBL1XR1 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:1348910 6480464 (+)-JQ1 compound promotes the reaction [panobinostat affects the expression of TBL1XR1 mRNA], panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of TBL1XR1 mRNA] CTD PMID:26733615 panobinostat affects expression ISO RGD:1348910 6480464 panobinostat affects the expression of TBL1XR1 mRNA CTD PMID:26733615 paracetamol decreases expression ISO RGD:1348910 6480464 Acetaminophen results in decreased expression of TBL1XR1 mRNA CTD PMID:21420995 , PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TBL1XR1 mRNA CTD PMID:33387578 phenylmercury acetate decreases expression ISO RGD:1348910 6480464 Phenylmercuric Acetate results in decreased expression of TBL1XR1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1348910 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1558421 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of TBL1XR1 mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO RGD:1558421 6480464 pirinixic acid results in increased expression of TBL1XR1 mRNA CTD PMID:18301758 more ... potassium chromate decreases expression ISO RGD:1348910 6480464 potassium chromate(VI) results in decreased expression of TBL1XR1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1348910 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBL1XR1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1558421 6480464 Pregnenolone Carbonitrile results in increased expression of TBL1XR1 mRNA CTD PMID:28903501 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of TBL1XR1 mRNA CTD PMID:25905778 SB 431542 multiple interactions ISO RGD:1348910 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1558421 6480464 Silver results in decreased expression of TBL1XR1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1558421 6480464 Silver results in decreased expression of TBL1XR1 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1558421 6480464 sodium arsenite results in decreased expression of TBL1XR1 mRNA CTD PMID:25270620 tert-butyl hydroperoxide affects expression ISO RGD:1348910 6480464 tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA CTD PMID:23410634 tert-butyl hydroperoxide decreases methylation ISO RGD:1348910 6480464 tert-Butylhydroperoxide results in decreased methylation of TBL1XR1 intron CTD PMID:29432895 testosterone increases expression ISO RGD:1558421 6480464 Testosterone deficiency results in increased expression of TBL1XR1 mRNA CTD PMID:33848595 tetrachloroethene increases expression ISO RGD:1558421 6480464 Tetrachloroethylene results in increased expression of TBL1XR1 mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:1558421 6480464 Carbon Tetrachloride affects the expression of TBL1XR1 mRNA CTD PMID:17484886 thimerosal increases expression ISO RGD:1348910 6480464 Thimerosal results in increased expression of TBL1XR1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TBL1XR1 mRNA CTD PMID:23411599 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of TBL1XR1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TBL1XR1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1348910 6480464 torcetrapib results in increased expression of TBL1XR1 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1348910 6480464 trichostatin A results in decreased expression of TBL1XR1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1348910 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1558421 6480464 trimellitic anhydride results in increased expression of TBL1XR1 mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:1558421 6480464 triptonide results in decreased expression of TBL1XR1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1558421 6480464 troglitazone results in decreased expression of TBL1XR1 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1558421 6480464 Valproic Acid affects the expression of TBL1XR1 mRNA CTD PMID:17292431 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of TBL1XR1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:1348910 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1348910 6480464 Valproic Acid results in decreased expression of TBL1XR1 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1558421 6480464 Valproic Acid results in decreased expression of TBL1XR1 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:1348910 6480464 Valproic Acid affects the expression of TBL1XR1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of TBL1XR1 mRNA CTD PMID:19015723 zoledronic acid increases expression ISO RGD:1348910 6480464 zoledronic acid results in increased expression of TBL1XR1 mRNA CTD PMID:20977926